D-0719-2026 Class II Ongoing

Recalled by Rohto-Mentholatum (Vietnam) Co., Ltd. — Ho Chi Minh, N/A

FDA drug recall D-0719-2026 was initiated by Rohto-Mentholatum (Vietnam) Co., Ltd. on Jul 14, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 65219 cartons.

Recall details

Product Type
Drugs
Report Date
Jul 29, 2026
Initiation Date
Jul 14, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
65219 cartons

Product description

Rohto Cooling Eye Drops Digi Eye (hypromellose 0.35%, tetrahydrozoline HCl 0.05%), Sterile, 0.4 FL OZ (13 mL), Distributed by: The Mentholatum Company, Orchard Park, NY 14127, Made in Vietnam, UPC 310742010602, NDC 10742-8175-1

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

Nationwide within the United States

Code information

Lot #: 4B1V, 4B1VA, Exp. Date 2027/01; 4J1V, Exp. Date 2027/09

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0719-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0719-2026. Report a data issue: hello@regdatalab.com.